Status:
COMPLETED
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Lead Sponsor:
Carelon Research
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Heparin Induced Thrombocytopenia
Eligibility:
All Genders
Brief Summary
HIT-RADIO is a study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals. The study will collect and analyse information that is already in ...
Detailed Description
HIT-RADIO is a retrospective chart-review study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals associated with the Transfusion Medicine...
Eligibility Criteria
Inclusion
- All subjects with a positive heparin PF-4 antibody test occurring between 1/21/2008 and 9/25/2008
- Medical record available for the admission during which the positive heparin PF-4 antibody test was obtained
Exclusion
- None
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
668 Patients enrolled
Trial Details
Trial ID
NCT01178333
Start Date
June 1 2010
End Date
December 1 2010
Last Update
May 22 2015
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242
2
Tulane University
New Orleans, Louisiana, United States, 70112
3
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States, 21201
4
Johns Hopkins
Baltimore, Maryland, United States, 21205